Bacterial Diseases
Bacterial Diseases(细菌性疾病)
Bacterial Diseases 相关产品(602)
- GC490711-Palmitoyl-d9 Lysophosphatidic Acid纯度: >99.00%
An internal standard for the quantification of 1-palmitoyl lysophosphatidic acid
- GC49076Tilmicosin-d3CAS: 2714486-61-8纯度: >99.00%
An internal standard for the quantification of tilmicosin
- GC49096Cobaltic Protoporphyrin IX (chloride)CAS: 102601-60-5纯度: >95.00% / >98.00%
Cobaltic Protoporphyrin IX (chloride)是一种高价钴配位卟啉化合物。Cobaltic Protoporphyrin IX (chloride)通过上调HO-1的抗氧化、抗炎和细胞保护功能，有助于减轻免疫相关的肾脏损伤。
- GC49101Enrofloxacin-d5CAS: 1173021-92-5纯度: >99.00%
An internal standard for the quantification of enrofloxacin
- GC49134Flumequine-13C3CAS: 1185049-09-5纯度: >98.00%
An internal standard for the quantification of flumequine
- GC49187N-3-hydroxydecanoyl-DL-Homoserine lactoneCAS: 929222-14-0纯度: >98.00%
A bacterial quorum-sensing signaling molecule
- GC49188Sarafloxacin-d8 (hydrochloride)CAS: 2733145-07-6纯度: >99.00%
An internal standard for the quantification of sarafloxacin
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC49068 | 16-Epiestriol | 547-81-9 | >90.00% | |
A metabolite of estrone | ||||
| GC49071 | 1-Palmitoyl-d9 Lysophosphatidic Acid | - | >99.00% | |
An internal standard for the quantification of 1-palmitoyl lysophosphatidic acid | ||||
| GC49073 | Oxanosine | 80394-72-5 | >90.00% | |
A guanosine analog with diverse biological activities | ||||
| GC49076 | Tilmicosin-d3 | 2714486-61-8 | >99.00% | |
An internal standard for the quantification of tilmicosin | ||||
| GC49079 | C82 | 691862-35-8 | >98.00% | |
An Mtb CdnP inhibitor | ||||
| GC49096 | Cobaltic Protoporphyrin IX (chloride) | 102601-60-5 | >95.00% / >98.00% | |
Cobaltic Protoporphyrin IX (chloride)是一种高价钴配位卟啉化合物。Cobaltic Protoporphyrin IX (chloride)通过上调HO-1的抗氧化、抗炎和细胞保护功能，有助于减轻免疫相关的肾脏损伤。 | ||||
| GC49099 | Tuftsin (human) (trifluoroacetate salt) | - | >95.00% | |
A phagocytosis-stimulating peptide | ||||
| GC49100 | Desmethyl Ofloxacin (hydrochloride) | 402930-70-5 | >98.00% | |
A metabolite of ofloxacin | ||||
| GC49101 | Enrofloxacin-d5 | 1173021-92-5 | >99.00% | |
An internal standard for the quantification of enrofloxacin | ||||
| GC49103 | Aromadendrene | 489-39-4 | >80.00% | |
A sesquiterpene with diverse biological activities | ||||
| GC49105 | Tebipenem (hydrate) | - | >95.00% | |
A carbenapenem antibiotic | ||||
| GC49115 | Desacetylcefotaxime (potassium salt) | - | >95.00% | |
An active metabolite of cefotaxime | ||||
| GC49134 | Flumequine-13C3 | 1185049-09-5 | >98.00% | |
An internal standard for the quantification of flumequine | ||||
| GC49139 | CAY10784 | 1245814-52-1 | >98.00% | |
A STAT3 inhibitor | ||||
| GC49142 | Isorhoifolin | 552-57-8 | >98.00% | |
A flavonoid glycoside with diverse biological activities | ||||
| GC49144 | NAG-thiazoline | 179030-22-9 | >98.00% | |
An OGA inhibitor | ||||
| GC49151 | Neospiramycin I | 70253-62-2 | >95.00% | |
A macrolide antibiotic | ||||
| GC49162 | N-Demethylvancomycin (hydrochloride) | 198774-23-1 | >95.00% | |
A glycopeptide antibiotic | ||||
| GC49170 | Biotin (S)-sulfoxide | 10406-89-0 | >95.00% | |
An inactive metabolite of biotin | ||||
| GC49187 | N-3-hydroxydecanoyl-DL-Homoserine lactone | 929222-14-0 | >98.00% | |
A bacterial quorum-sensing signaling molecule | ||||
| GC49188 | Sarafloxacin-d8 (hydrochloride) | 2733145-07-6 | >99.00% | |
An internal standard for the quantification of sarafloxacin | ||||
| GC49200 | Biotin (R)-Sulfoxide | 3376-83-8 | >98.00% | |
A metabolite of biotin | ||||
| GC49208 | Maduramicin (ammonium salt) | 84878-61-5 | >98.00% | |
A polyether ionophore antibiotic | ||||
| GC49267 | Hygromycin B-d4 | - | >99.00% | |
An internal standard for the quantification of hygromycin | ||||